View in EDS HTML Full Text PDF Full Text

Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third‐ or Later‐Line Chemotherapy for CLDN18.2‐Positive and HER2‐Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol.

Saved in:
Bibliographic Details
Title: Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third‐ or Later‐Line Chemotherapy for CLDN18.2‐Positive and HER2‐Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol.
Authors: Maeda, Osamu1 (AUTHOR) maeda.osamu.s2@f.mail.nagoya‐u.ac.jp, Tanaka, Chie2 (AUTHOR), Furukawa, Kazuhiro3 (AUTHOR), Miyata, Kazushi4 (AUTHOR), Shimizu, Dai2 (AUTHOR), Sugita, Shizuki4 (AUTHOR), Nakanishi, Koki2 (AUTHOR), Hirose, Takashi3 (AUTHOR), Mizuno, Kazuyuki1 (AUTHOR), Kinoshita, Fumie5 (AUTHOR), Kuwatsuka, Yachiyo5 (AUTHOR), Ando, Masahiko5 (AUTHOR), Kanda, Mitsuro2 (AUTHOR), Kawashima, Hiroki3 (AUTHOR), Ando, Yuichi1 (AUTHOR)
Source: Cancer Medicine. May2026, Vol. 15 Issue 5, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194013625
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third‐ or Later‐Line Chemotherapy for CLDN18.2‐Positive and HER2‐Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Maeda%2C+Osamu%22">Maeda, Osamu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> maeda.osamu.s2@f.mail.nagoya‐u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Tanaka%2C+Chie%22">Tanaka, Chie</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Furukawa%2C+Kazuhiro%22">Furukawa, Kazuhiro</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miyata%2C+Kazushi%22">Miyata, Kazushi</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shimizu%2C+Dai%22">Shimizu, Dai</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sugita%2C+Shizuki%22">Sugita, Shizuki</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakanishi%2C+Koki%22">Nakanishi, Koki</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hirose%2C+Takashi%22">Hirose, Takashi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mizuno%2C+Kazuyuki%22">Mizuno, Kazuyuki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kinoshita%2C+Fumie%22">Kinoshita, Fumie</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuwatsuka%2C+Yachiyo%22">Kuwatsuka, Yachiyo</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ando%2C+Masahiko%22">Ando, Masahiko</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kanda%2C+Mitsuro%22">Kanda, Mitsuro</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kawashima%2C+Hiroki%22">Kawashima, Hiroki</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ando%2C+Yuichi%22">Ando, Yuichi</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. May2026, Vol. 15 Issue 5, p1-5. 5p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194013625
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.71981
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 1
    Titles:
      – TitleFull: Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third‐ or Later‐Line Chemotherapy for CLDN18.2‐Positive and HER2‐Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Maeda, Osamu
      – PersonEntity:
          Name:
            NameFull: Tanaka, Chie
      – PersonEntity:
          Name:
            NameFull: Furukawa, Kazuhiro
      – PersonEntity:
          Name:
            NameFull: Miyata, Kazushi
      – PersonEntity:
          Name:
            NameFull: Shimizu, Dai
      – PersonEntity:
          Name:
            NameFull: Sugita, Shizuki
      – PersonEntity:
          Name:
            NameFull: Nakanishi, Koki
      – PersonEntity:
          Name:
            NameFull: Hirose, Takashi
      – PersonEntity:
          Name:
            NameFull: Mizuno, Kazuyuki
      – PersonEntity:
          Name:
            NameFull: Kinoshita, Fumie
      – PersonEntity:
          Name:
            NameFull: Kuwatsuka, Yachiyo
      – PersonEntity:
          Name:
            NameFull: Ando, Masahiko
      – PersonEntity:
          Name:
            NameFull: Kanda, Mitsuro
      – PersonEntity:
          Name:
            NameFull: Kawashima, Hiroki
      – PersonEntity:
          Name:
            NameFull: Ando, Yuichi
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 20457634
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer Medicine
              Type: main
ResultId 1